26.05.2015 • News

Chemours Closes on Notes, Credit Facilities

Chemours, DuPont's new stand-alone incorporating its Performance Chemicals business, has completed an offering of $1,350 million 6.625% senior notes due in 2023, $750 million 7% senior notes due in 2025 and €360 million 6.125% senior notes due in 2023.

The company, which will be formally spun off from the US chemical giant on July 1 of this year, also has entered into a credit agreement with a syndicate of banks providing for a seven-year $1.5 billion senior secured Term Loan B Facility and a five-year $1.0 billion senior secured Revolving Credit Facility.

Proceeds from the transactions have been used to fund a distribution to DuPont of approximately $3.9 billion, in recognition of the assets the former owner contributed.

"It is critical to get the backing from the debt capital markets as we near the launch of The Chemours Company as an independent company on July 1. We are pleased with the market reception following our debt roadshows, which has been very favorable and supportive of our strategic plans for Chemours," said CEO-designate Mark Vergnano.

The company also has announced the appointment of E. Bryan Snell as president of its Titanium Technologies business, with immediate effect. Snell, who joined the former DuPont division in 1992 as production unit manager, replaces BC Chong, who led the business since 2011.

Interview

Driving Transformation
Interconnected Global Chemicals Logistics

Driving Transformation

DP World is reshaping global chemical supply chains. Christene Smith of CHEManager interviews Markus Kanis, Global SVP Chemicals, on the company’s roadmap, new technologies, and the evolving demands of global trade.

Special Issue

Circular Plastics Economy
Explore the Future of Plastics

Circular Plastics Economy

This special CHEManager issue explores the industry’s pivotal shift towards a more sustainable, circular plastics value chain. Readers will find expert analysis and real-world solutions for today’s most pressing recycling and regulatory challenges.

most read